SCHEMBL7697735

SCHEMBL7697735

Brc1c2ccccc2c(Br)c2nc(-c3cccs3)c(-c3ccsc3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 5/20 0.41
ADORA2A P29274 2/20 0.40
DHFR P00374 1/20 0.40
PTGER1 P34995 1/20 0.37
ENPP1 P22413 1/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
TDO2 P48775 1/20 0.36
FYN P06241 1/20 0.36
PPARG P37231 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693614 0.89 ENPP1 (0.43) ADORA2APTGER1ENPP1MAPTGAA
SCHEMBL7691803 0.87 RPS6KB2 (0.51) RPS6KB2ADORA2ADHFRALDH1A1KDM4E
SCHEMBL7699647 0.76 RPS6KB2 (0.73) RPS6KB2ADORA2AALDH1A1KDM4EMAPT
SCHEMBL1644280 0.76 MEN1 (0.47) RPS6KB2ADORA2ADHFRALDH1A1KDM4E
SCHEMBL21066891 0.70 DHFR (0.47) RPS6KB2ADORA2ADHFRALDH1A1KDM4E
SCHEMBL12715488 0.69 DHFR (0.53) RPS6KB2ADORA2ADHFRALDH1A1KDM4E
SCHEMBL7692593 0.69 DHFR (0.43) ADORA2ADHFRALDH1A1KDM4EMAPT
SCHEMBL769338 0.68 CYP2A6 (0.50) ALDH1A1KDM4EMAPTMEN1HPGD
SCHEMBL7695816 0.66 ALDH1A1 (0.43) ADORA2AALDH1A1KDM4EMAPTMEN1
SCHEMBL21313201 0.65 ADORA2A (0.49) ADORA2ADHFRALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed